HCID 23498818, compound → HCID 44299304, compound

HRID 1836154Notes

Reaction equation

HRID 1836154 reaction equation
[OH:1][CH:2]1[CH2:7][CH2:6][N:5]([CH2:8][CH2:9][CH2:10][C:11]2[C:19]3[CH2:18][CH2:17][CH2:16][CH2:15][C:14]=3[NH:13][C:12]=2[CH:20]=O)[CH2:4][CH2:3]1.[CH2:22]([S:24]([C:27]1[CH:28]=[C:29]2[C:33](=[CH:34][CH:35]=1)[NH:32][C:31](=[O:36])[CH2:30]2)(=[O:26])=[O:25])[CH3:23]>>[CH2:22]([S:24]([C:27]1[CH:28]=[C:29]2[C:33](=[CH:34][CH:35]=1)[NH:32][C:31](=[O:36])/[C:30]/2=[CH:20]\[C:12]1[NH:13][C:14]2[CH2:15][CH2:16][CH2:17][CH2:18][C:19]=2[C:11]=1[CH2:10][CH2:9][CH2:8][N:5]1[CH2:4][CH2:3][CH:2]([OH:1])[CH2:7][CH2:6]1)(=[O:25])=[O:26])[CH3:23]

Participants

3

Reactant 2

HCID 23498818HCID 23498818, compoundHCID 23498854HCID 23498854, compound

Product 1

HCID 44299304HCID 44299304, compoundYield 31.1%

Procedure

3-[3-(4-Hydroxy-piperidin-1-yl)-propyl]-4,5,6,7-tetrahydro-1H-indole-2-carbaldehyde (58 mg, 0.2 mmol), prepared as described in Example 20, was condensed with 5-ethylsulfonyloxindole (69 mg, 0.2 mmol, 65%pure) following the procedure used in Example 1 to provide 31 mg of the desired compound.

Sources & evidence

ORD record
ord-adafcd038c6a42bab23277f18face2fa
Source dataset
uspto-grants-2004_08
Patent number
US06777417B2

Reaction notes

Loading…